Canada · Delayed Price · Currency is CAD Healwell AI Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 revenue was CAD 33 million, flat year-over-year, with positive adjusted EBITDA and strong operating cash flow. The business is transitioning to recurring enterprise sales, with robust AI adoption and a healthy pipeline, targeting a 10% adjusted EBITDA margin by year-end.
-
Q1 2026 saw revenue surge 316% year-over-year to CAD 33.2 million, driven by the Orion Health acquisition and organic AI growth, with positive adjusted EBITDA and improved margins. The company is focused on scaling globally, leveraging strong public sector tailwinds and a robust pipeline across AI and Healthcare Software.
Fiscal Year 2025
-
Revenue surged 427% to CAD 103.8M in 2025, driven by Orion Health acquisition and global expansion, with first positive Adjusted EBITDA achieved. AI and software segments both saw rapid growth, and the company targets 50% AI revenue growth and a 10% EBITDA margin in 2026.
-
Q3 2025 saw a 354% revenue increase to CAD 30.4M, driven by acquisitions and organic growth, with positive Adjusted EBITDA for the second consecutive quarter. The business is now focused on AI and software, expanding globally, and expects further margin improvements and commercial AI validation in 2026.
-
Q2 2025 saw record revenue of $40.5M (+645% YoY) and first positive adjusted EBITDA, driven by the Orion Health acquisition and strong AI/software growth. The company is transitioning to a pure-play AI software model, divesting clinical units, and expects continued margin expansion and global reach.
-
Q1 2025 revenue surged 208% year-over-year to CAD 14.1 million, driven by organic growth and acquisitions. The Orion Health acquisition, closed in April, is set to add CAD 100 million in annual revenue and drive positive adjusted EBITDA for 2025.
Fiscal Year 2024
-
Record 2024 revenue and gross profit were driven by acquisitions and AI commercialization, with the Orion Health acquisition set to add significant recurring revenue and EBITDA positivity in 2025. Gross margin improved to 44% for the year, and the company expects further growth and profitability as integration and M&A continue.
-
Q3 2024 saw record revenue and gross profit, driven by acquisitions and rapid growth in AI and data science. The company targets a CAD 100 million annualized revenue run rate and profitability in 2025, with strong momentum in new MSAs and strategic partnerships.
-
Revenue grew 204% year-over-year to CAD 5.44 million, driven by acquisitions and organic growth, with gross margin rising to 71%. Strategic acquisitions, new AI Co-Pilots, and strong cash position support a revenue run rate target of CAD 100 million by year-end.